News on Oxford BioMedica from BioPortfolio.com http://www.BioPortfolio.com Consolidated Oxford BioMedica news from BioPortfolio.com Wed, 10 Feb 2010 12:04:51 GMT en Inovio Biomedica Reports Interim Data on Its Cervical Cancer Therapeutic Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039917&HITNO=0&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039917&THISHREF=http://c.moreover.com/click/here.pl%3fz2538470344%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039917&HITNO=0&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039917&THISHREF=http://c.moreover.com/click/here.pl%3fz2538470344%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Inovio Biomedica Reports Interim Data on Its Cervical Cancer Therapeutic Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039910&HITNO=1&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039910&THISHREF=http://c.moreover.com/click/here.pl%3fz2538463981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039910&HITNO=1&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039910&THISHREF=http://c.moreover.com/click/here.pl%3fz2538463981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: ALS Therapy Development Institute And Oxford BioMedica Begin Second Phase Of Collaboration To Develop Gene Thehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010488&HITNO=2&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010488&THISHREF=http://c.moreover.com/click/here.pl%3fz2522488307%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010488&HITNO=2&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010488&THISHREF=http://c.moreover.com/click/here.pl%3fz2522488307%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Oxford BioMedica extends gene therapy collaboration in Lou Gehrigs diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010530&HITNO=3&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010530&THISHREF=http://c.moreover.com/click/here.pl%3fz2522500148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010530&HITNO=3&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010530&THISHREF=http://c.moreover.com/click/here.pl%3fz2522500148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comScience Business: Medical News: ALS Therapy Development Institute And Oxford BioMedica Begin Second Phase Of Collaboration To Develop Gene Therapies For ALS, UKhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010859&HITNO=4&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010859&THISHREF=http://c.moreover.com/click/here.pl%3fz2522654684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010859&HITNO=4&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010859&THISHREF=http://c.moreover.com/click/here.pl%3fz2522654684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013117&HITNO=5&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013117&THISHREF=http://c.moreover.com/click/here.pl%3fz2523615678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013117&HITNO=5&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013117&THISHREF=http://c.moreover.com/click/here.pl%3fz2523615678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPhoenix Business Journal: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=6&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=6&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Finance: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=7&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=7&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012525&HITNO=8&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012525&THISHREF=http://c.moreover.com/click/here.pl%3fz2523454846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012525&HITNO=8&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012525&THISHREF=http://c.moreover.com/click/here.pl%3fz2523454846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Ribonucleic Acid (RNA) Therapeutics - Strong Potential To Address Unmet Needs In Pharma - New Market Report Puhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005377&HITNO=9&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005377&THISHREF=http://c.moreover.com/click/here.pl%3fz2520344895%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005377&HITNO=9&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005377&THISHREF=http://c.moreover.com/click/here.pl%3fz2520344895%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOfficialSpin: Ribonucleic Acid (RNA) Therapeutics - Strong Potential To Address Unmet Needs In Pharma - New Market Report Publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005337&HITNO=10&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005337&THISHREF=http://c.moreover.com/click/here.pl%3fz2520329072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005337&HITNO=10&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005337&THISHREF=http://c.moreover.com/click/here.pl%3fz2520329072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOfficialWire: Therapure Biopharma signs manufacturing agreement with LFB Biomedicamentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002238&HITNO=11&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002238&THISHREF=http://c.moreover.com/click/here.pl%3fz2518801360%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002238&HITNO=11&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002238&THISHREF=http://c.moreover.com/click/here.pl%3fz2518801360%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: The Trout Group LLC and BioBusiness.TV Team to Produce '60 Second Pitch' Videos for Biotechnology Companieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995363&HITNO=12&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995363&THISHREF=http://c.moreover.com/click/here.pl%3fz2515617061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995363&HITNO=12&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995363&THISHREF=http://c.moreover.com/click/here.pl%3fz2515617061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: LFB awards Therapure plasma protein contracthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999222&HITNO=13&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999222&THISHREF=http://c.moreover.com/click/here.pl%3fz2517371037%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999222&HITNO=13&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999222&THISHREF=http://c.moreover.com/click/here.pl%3fz2517371037%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOutsourcing Pharma: The Trout Group LLC and BioBusiness.TV Team to Produce '60 Second Pitch' Videos for Biotechnology Companieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991243&HITNO=14&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991243&THISHREF=http://c.moreover.com/click/here.pl%3fz2513623538%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991243&HITNO=14&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Oxford%20BioMedica&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991243&THISHREF=http://c.moreover.com/click/here.pl%3fz2513623538%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via Yahoo!: